# South Texas Blood and Tissue Center – FDA Inspection, Jun 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/south-texas-blood-and-tissue-center/cf26438b-a695-451c-b113-dd13cda8fe58
Source feed: FDA_Inspections

> FDA inspection 1171968 of South Texas Blood and Tissue Center, June 10, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171968
- Company Name: South Texas Blood and Tissue Center
- Inspection Date: 2022-06-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1061994 - 2018-06-27
- FDA Inspection 952375 - 2015-11-30
- FDA Inspection 893656 - 2014-09-02
- FDA Inspection 848085 - 2013-09-12
- FDA Inspection 770038 - 2012-02-29

Company: https://www.keypedia.com/companies/south-texas-blood-and-tissue-center/6a424efb-042e-434f-95e1-b4babdff79a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d